Bixiye
P77-19 New Medical, Medical Drug and Behavioral Health Policy Management Updates – Effective January 6, 2019
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2019
Natiijooyinka Raadinta
Soo bandhiga 2731 - 2740 ee natiijooyinka 3700
Bixiye
P83-19 Blue Cross Discontinues Vendor Relationship with Magellan
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2019
Bixiye
QP101-19 InterQual ® Level of Care Criteria for Concurrent Review Authorizations
Taariikhda uu dhaqangalayo Barnaamijka: Nov 27, 2019
Bixiye
QP100-19 Blue Distinction Center and Blue Distinction Center + Designations Being Applied to Ambulatory Surgical Centers for Spine, Knee and Hip Services
Taariikhda uu dhaqangalayo Barnaamijka: Nov 27, 2019
Bixiye
QP97-19 Commercial Product Changes for 2020
Taariikhda uu dhaqangalayo Barnaamijka: Nov 27, 2019
Bixiye
P54R2-19 Update: Precertification for Commercial Inpatient Admissions
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2019
Bixiye
P82-19 Reimbursement Policy Clarification to Unlisted Codes for Commercial & Medicare Products
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2019
Bixiye
P80-19 2020 Renewal Changes Summary for Primary Care Clinic Providers
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2019
Bixiye
QP86-19 Pharmacy Benefit Exclusion for Invermectin Cream 1%
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2019
Bixiye
QP90-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: tadalafil
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2019